FDA approves drug for HER-2 unresectable or metastatic NSCLC

August 23, 2022

Posted in FDA News, Research, Science Made SimpleTagged #fdaapprovals, #sciencemadesimple, HER2

Grantee publishes work on disparities

June 29, 2022

Posted in Research, Women & Lung CancerTagged #womeninlungcancer

#TogetherSeparately: ASCO Update

Posted in #TogetherSeparately, Research, Women & Lung CancerTagged #womeninlungcancer, Research, togetherseparately

Former LCRF grantees and new SAB member publish work on targeting resistance

June 24, 2022

Posted in ResearchTagged #inthenews

Lung Cancer Mutation Consortium Sites Initiate LEADER Trial

June 3, 2022

Posted in Announcements, ResearchTagged LCMC

Potential target for SCLC discovered

April 19, 2022

Posted in In the News, ResearchTagged #inthenews, Research

Lung Cancer and KRAS: Behind the Scenes in Research

March 29, 2022

Posted in Partnerships, Research, Women & Lung CancerTagged KRAS

Possible new immunotherapy resistance mechanism identified

March 24, 2022

Posted in In the News, ResearchTagged #goodnews, #inthenews

LCRF announces 2022 Request for Proposals

March 10, 2022

Posted in Announcements, Research

FDA approves nivolumab with chemotherapy as neoadjuvant treatment for certain patients with resectable NSCLC

March 7, 2022

Posted in FDA News, ResearchTagged #fdaapprovals, Research